Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Quesada

Showing results (41-50 of 202) with videos related to

Pageof 21
Sort By:
Marine Drugs|October 26, 2017
Pleiotropic Role of Puupehenones in Biomedical ResearchBeatriz Martínez-Poveda, Ana R Quesada, Miguel Ángel Medina
European Journal of Pharmacology|June 1, 2005
Hypericin in the dark inhibits key steps of angiogenesis in vitroBeatriz Martínez-Poveda, Ana R Quesada, Miguel Angel Medina
Anticancer Research|February 19, 2002
A re-evaluation of fumagillin selectivity towards endothelial cellsS Rodriguez-Nieto, M A Medina, A R Quesada
Chemosphere|February 17, 2020
Excretion of non-metabolized insecticides in honeydew of striped pine scaleCarlos R Quesada, Michael E Scharf, Clifford S Sadof
Seminars in Oncology|December 1, 1984
Biologic therapy of hairy cell leukemiaJ R Quesada, E M Hersh, J U Gutterman
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|March 11, 2020
Student Medical Interpreters: A Double-Edged SwordPompeyo R Quesada, Roberto N Solis, Jessica R Levi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1985
Phase II study of interferon alpha in metastatic renal-cell carcinoma: a progress reportJ R Quesada, D A Swanson, J U Gutterman
The American Journal of Medicine|October 1, 1986
Benign hypergammaglobulinemic purpura of Waldenström associated with Sjögren's syndrome. Case report and review of immunologic aspectsJ E Ferreiro, G Pasarin, R Quesada, et al.
Medicinal Research Reviews|May 3, 2006
Anti-angiogenic drugs: from bench to clinical trialsAna R Quesada, Ramón Muñoz-Chápuli, Miguel A Medina
International Journal of Cancer|June 28, 2005
Hyperforin, a bio-active compound of St. John's Wort, is a new inhibitor of angiogenesis targeting several key steps of the processBeatriz Martínez-Poveda, Ana R Quesada, Miguel Angel Medina
Pageof 21

Showing results (41-50 of 202) with videos related to

Sort By:
Pageof 21
Marine Drugs|October 26, 2017
Pleiotropic Role of Puupehenones in Biomedical ResearchBeatriz Martínez-Poveda, Ana R Quesada, Miguel Ángel Medina
European Journal of Pharmacology|June 1, 2005
Hypericin in the dark inhibits key steps of angiogenesis in vitroBeatriz Martínez-Poveda, Ana R Quesada, Miguel Angel Medina
Anticancer Research|February 19, 2002
A re-evaluation of fumagillin selectivity towards endothelial cellsS Rodriguez-Nieto, M A Medina, A R Quesada
Chemosphere|February 17, 2020
Excretion of non-metabolized insecticides in honeydew of striped pine scaleCarlos R Quesada, Michael E Scharf, Clifford S Sadof
Seminars in Oncology|December 1, 1984
Biologic therapy of hairy cell leukemiaJ R Quesada, E M Hersh, J U Gutterman
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|March 11, 2020
Student Medical Interpreters: A Double-Edged SwordPompeyo R Quesada, Roberto N Solis, Jessica R Levi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1985
Phase II study of interferon alpha in metastatic renal-cell carcinoma: a progress reportJ R Quesada, D A Swanson, J U Gutterman
The American Journal of Medicine|October 1, 1986
Benign hypergammaglobulinemic purpura of Waldenström associated with Sjögren's syndrome. Case report and review of immunologic aspectsJ E Ferreiro, G Pasarin, R Quesada, et al.
Medicinal Research Reviews|May 3, 2006
Anti-angiogenic drugs: from bench to clinical trialsAna R Quesada, Ramón Muñoz-Chápuli, Miguel A Medina
International Journal of Cancer|June 28, 2005
Hyperforin, a bio-active compound of St. John's Wort, is a new inhibitor of angiogenesis targeting several key steps of the processBeatriz Martínez-Poveda, Ana R Quesada, Miguel Angel Medina
Pageof 21